-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

BRIEF-Liminal Biosciences Announces Priorities For 2023

Reuters · 01/06/2023 16:08
BRIEF-Liminal Biosciences Announces Priorities For 2023

- Liminal BioSciences Inc LMNL.O:

  • LIMINAL BIOSCIENCES ANNOUNCES PRIORITIES FOR 2023

  • LIMINAL BIOSCIENCES INC - PLANS TO DIVEST ITS REMAINING NON-CORE ASSETS, TO FURTHER EXTEND RUNWAY

  • LIMINAL BIOSCIENCES INC - SELECTION OF INITIAL TARGET INDICATION FOR LMNL6511 EXPECTED IN COMING MONTHS

  • LIMINAL BIOSCIENCES INC - OXER1 ANTAGONIST DEVELOPMENT PROGRAM PROGRESSING TO IDENTIFICATION OF LEAD PRECLINICAL DRUG CANDIDATE IN H1 2023

  • LIMINAL BIOSCIENCES INC - CLOSED DECEMBER 2022 WITH JUST OVER CAD 37 MILLION CASH ON HAND, EXPECTING TO PROVIDE A RUNWAY INTO EARLY 2024

Source text for Eikon: ID:

Further company coverage: LMNL.O


((Reuters.Briefs@thomsonreuters.com;;))